Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Tizona Therapeutics, Inc
IDEAYA Biosciences
UNC Lineberger Comprehensive Cancer Center
VLP Therapeutics
Novartis
University of Chicago
Sanford Health
Bicara Therapeutics
MacroGenics
Incyte Corporation
DEKA Biosciences
Medical University of South Carolina
Carisma Therapeutics Inc
Inhibrx Biosciences, Inc
Bayer
Celldex Therapeutics
Ikena Oncology
Fate Therapeutics
Seagen Inc.
Fate Therapeutics
Silverback Therapeutics
Incyte Corporation
Lytix Biopharma AS